Facebook Linkedin RSS Twitter Youtube
Home 2024

FDA policy

FDA Approves Pfizer’s One-Time Gene Therapy BEQVEZ for Hemophilia B
Drug Discovery

FDA Approves Pfizer’s One-Time Gene Therapy BEQVEZ for Hemophilia B

Immunotherapy Safely Boosted with Particle-Bound Cytokines in Tumor Models
Cancer

Immunotherapy Safely Boosted with Particle-Bound Cytokines in Tumor Models

Is Gene Therapy Nearing a Tipping Point?
Drug Discovery

Is Gene Therapy Nearing a Tipping Point?

New FDA Guidance Impacts the CAR-T Industry
Bioprocessing

New FDA Guidance Impacts the CAR-T Industry

Game On for Concussion Therapies
Insights

Game On for Concussion Therapies

Phage Therapy Temporarily Held Recurrent Enterococcal Infection at Bay
Infectious Diseases

Phage Therapy Temporarily Held Recurrent Enterococcal Infection at Bay

Digital Tech and Innovative Biomanufacturing
Bioprocessing

Digital Tech and Innovative Biomanufacturing

The First CRISPR Drug: Vertex Pharmaceuticals’ Casgevy Wins U.K. Approval for Sickle Cell Disease
Genome Editing

The First CRISPR Drug: Vertex Pharmaceuticals’ Casgevy Wins U.K. Approval for Sickle Cell Disease

CRISPR Prime Time? FDA Advisory Committee Evaluates Vertex Exa-Cel Therapy for Sickle Cell Disease
Genome Editing

CRISPR Prime Time? FDA Advisory Committee Evaluates Vertex Exa-Cel Therapy for Sickle Cell Disease

How Church and Langer Make the Impossible Possible
Drug Discovery

How Church and Langer Make the Impossible Possible

123...8Page 2 of 8
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.